Contineum Therapeutics, Inc. Class A Common StockCTNMNASDAQ
Loading
ROE: Strong ReturnsStrong
Percentile Rank75
Studio
Year-over-Year Change

Return on equity

Latest
-22.98%
↑ 38% vs avg
Percentile
P75
Within normal range
Streak
1 yr
Consecutive declineStrong
Average
-37.32%
Historical baseline
PeriodValueYoY Change
2025-22.98%-7.7%
2024-21.34%+36.2%
2023-33.44%+45.8%
2022-61.76%-31.2%
2021-47.09%-